The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension

International Journal of Clinical Practice

Volumn 53, Issue 3, 1999, Pages 175-178

  Neutel, Joel M ^b   Smith, D H G ^c   Reilly, P A ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b Orange County Research Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ENALAPRIL; HYDROCHLOROTHIAZIDE; TELMISARTAN;

ADULT; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG COMPARISON; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VERTIGO;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SAFETY;

EID: 0032928319     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Phillips RA. Etiology, pathophysiology and treatment of left ventricular hypertrophy; focus on severe hypertension. J Cardiovasc Pharmacol 1993; 21(suppl 2): S55-S62.
2. Chalmers J. The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens 1993: 15(6): 1299-1313.
3. Johnston CL, Arnolda L, Hiwalari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs 1984; 27: 271-277.
4. Chalmers JP, Wing LMH, West MJ. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. Aust NZ J Med 1986; 6: 475-480.
5. Salvetti A, Innocenti PF, Lardella M. Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens 1987; 5(4): S139-S142.
6. Singer DRJ, Markandu ND, Shore A, MacGregor GA. Captopril and nifedipine in combination for moderate to severe hypertension. Hypertension 1987; 9: 629-633.
7. Dunlay MC, Fitzpatrick V, Chrysant S et al. Losartan potassium as initial therapy in patients with severe hypertension. J Hum Hypertens 1995: 9(11): 861-867.
8. Neutel JM, Smith DHG. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998; 15: 206-217.
9. Chuang C. The analysis of a titration study. Stat Med 1987; 6: 583-590.
10. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). National Institutes of Health; 1997. US Department of Health, Education, and Welfare publication NIH 98-4080.
11. Kaplan NM, Gifford RW Jr. Choice of initial therapy for hypertension. JAMA 1996; 275: 1577-1580.
12. Phillips RA. Etiology, pathophysiology, and treatment of left ventricular hypertrophy, focus on severe hypertension. J Cardiovasc Pharmacol 1993; 21(suppl 2): S55-S62.
13. Reid JL. Pharmacokinetic and pharmacodynamic aspects of the choice of components of combination therapy. J Hum Hypertens 1995; 9(suppl 4): S19-S23.
14. Neutel JM, Weber MA. Combination therapy with diuretics: an evolution of understanding. Am J Med 1996; 101(suppl 3A): 615-705.
15. Jackson E, Garrison J. Renin and angiotensin. In: Goodman L, Gilman A, Hardman J, Limbird L, Eds. The pharmacological basis of therapeutics. New York: McGraw Hill, 1996: 735-738.
16. Ruilope LM, Simpson RL, Toh J et al. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients. Blood Press 1996; 5: 32-40.
17. Campbell BC, Shepherd AN, Reid JL. Effects of the angiotensin converting enzyme inhibitor captopril in essential hypertension. Br J Clin Pharmacol 1982; 13: 213-217.
18. Omvik P, Tarazi RC, Bravo EL. Regulation of sodium balance in hypertension. Hypertension 1980; 2: 115-522.
19. Tikkanen I, Omvik P, Jensen HJ. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens 1995; 13: 1343-1351.